These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 18556336)
1. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P; Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336 [TBL] [Abstract][Full Text] [Related]
2. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Beer NL; Tribble ND; McCulloch LJ; Roos C; Johnson PR; Orho-Melander M; Gloyn AL Hum Mol Genet; 2009 Nov; 18(21):4081-8. PubMed ID: 19643913 [TBL] [Abstract][Full Text] [Related]
3. Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism. Pollin TI; Jablonski KA; McAteer JB; Saxena R; Kathiresan S; Kahn SE; Goldberg RB; Altshuler D; Florez JC; J Clin Endocrinol Metab; 2011 Jul; 96(7):E1142-7. PubMed ID: 21525158 [TBL] [Abstract][Full Text] [Related]
4. Functional glucokinase regulator gene variants have inverse effects on triglyceride and glucose levels, and decrease the risk of obesity in children. Horvatovich K; Bokor S; Polgar N; Kisfali P; Hadarits F; Jaromi L; Csongei V; Repasy J; Molnar D; Melegh B Diabetes Metab; 2011 Nov; 37(5):432-9. PubMed ID: 21511510 [TBL] [Abstract][Full Text] [Related]
5. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326. Ford BE; Chachra SS; Rodgers K; Moonira T; Al-Oanzi ZH; Anstee QM; Reeves HL; Schattenberg JM; Fairclough RJ; Smith DM; Tiniakos D; Agius L Mol Metab; 2023 Jun; 72():101722. PubMed ID: 37031802 [TBL] [Abstract][Full Text] [Related]
6. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Orho-Melander M; Melander O; Guiducci C; Perez-Martinez P; Corella D; Roos C; Tewhey R; Rieder MJ; Hall J; Abecasis G; Tai ES; Welch C; Arnett DK; Lyssenko V; Lindholm E; Saxena R; de Bakker PI; Burtt N; Voight BF; Hirschhorn JN; Tucker KL; Hedner T; Tuomi T; Isomaa B; Eriksson KF; Taskinen MR; Wahlstrand B; Hughes TE; Parnell LD; Lai CQ; Berglund G; Peltonen L; Vartiainen E; Jousilahti P; Havulinna AS; Salomaa V; Nilsson P; Groop L; Altshuler D; Ordovas JM; Kathiresan S Diabetes; 2008 Nov; 57(11):3112-21. PubMed ID: 18678614 [TBL] [Abstract][Full Text] [Related]
7. Genotype effects of glucokinase regulator on lipid profiles and glycemic status are modified by circulating calcium levels: results from the Korean Genome and Epidemiology Study. Kim OY; Kwak SY; Lim H; Shin MJ Nutr Res; 2018 Dec; 60():96-105. PubMed ID: 30527264 [TBL] [Abstract][Full Text] [Related]
8. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Sparsø T; Andersen G; Nielsen T; Burgdorf KS; Gjesing AP; Nielsen AL; Albrechtsen A; Rasmussen SS; Jørgensen T; Borch-Johnsen K; Sandbaek A; Lauritzen T; Madsbad S; Hansen T; Pedersen O Diabetologia; 2008 Jan; 51(1):70-5. PubMed ID: 18008060 [TBL] [Abstract][Full Text] [Related]
9. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768 [TBL] [Abstract][Full Text] [Related]
10. GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? Mohás M; Kisfali P; Járomi L; Maász A; Fehér E; Csöngei V; Polgár N; Sáfrány E; Cseh J; Sümegi K; Hetyésy K; Wittmann I; Melegh B Cardiovasc Diabetol; 2010 Nov; 9():79. PubMed ID: 21114848 [TBL] [Abstract][Full Text] [Related]
11. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520 [TBL] [Abstract][Full Text] [Related]
12. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598 [TBL] [Abstract][Full Text] [Related]
13. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084 [TBL] [Abstract][Full Text] [Related]
14. Functional Variant in the GCKR Gene Affects Lactate Levels Differentially in the Fasting State and During Hyperglycemia. López Rodríguez M; Fernandes Silva L; Vangipurapu J; Modi S; Kuusisto J; Kaikkonen MU; Laakso M Sci Rep; 2018 Oct; 8(1):15989. PubMed ID: 30375486 [TBL] [Abstract][Full Text] [Related]
15. Association of genetic variants with isolated fasting hyperglycaemia and isolated postprandial hyperglycaemia in a Han Chinese population. Kong X; Hong J; Chen Y; Chen L; Zhao Z; Li Q; Ge J; Chen G; Guo X; Lu J; Weng J; Jia W; Ji L; Xiao J; Shan Z; Liu J; Tian H; Ji Q; Zhu D; Zhou Z; Shan G; Yang W PLoS One; 2013; 8(8):e71399. PubMed ID: 23990951 [TBL] [Abstract][Full Text] [Related]
16. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study. Ling Y; Li X; Gu Q; Chen H; Lu D; Gao X BMC Med Genet; 2011 May; 12():66. PubMed ID: 21569451 [TBL] [Abstract][Full Text] [Related]
17. GCKR variants increase triglycerides while protecting from insulin resistance in Chinese children. Shen Y; Wu L; Xi B; Liu X; Zhao X; Cheng H; Hou D; Wang X; Mi J PLoS One; 2013; 8(1):e55350. PubMed ID: 23383164 [TBL] [Abstract][Full Text] [Related]
18. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019). Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233 [TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study. Vaxillaire M; Yengo L; Lobbens S; Rocheleau G; Eury E; Lantieri O; Marre M; Balkau B; Bonnefond A; Froguel P Diabetologia; 2014 Aug; 57(8):1601-10. PubMed ID: 24893864 [TBL] [Abstract][Full Text] [Related]
20. Early gene-diet interaction between glucokinase regulatory protein (GCKR) polymorphism, vegetable and fish intakes in modulating triglyceride levels in healthy adolescents. Tam CH; Wang Y; Lee HM; Luk AO; Tong PC; Chan MH; Ozaki R; Kong AP; So WY; Chan JC; Ma RC Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):951-8. PubMed ID: 26234566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]